Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Parechovirus | 1 | 2018 | 48 | 0.72 | Why? |
| Meningitis, Viral | 1 | 2018 | 97 | 0.66 | Why? |
| Picornaviridae Infections | 2 | 2018 | 544 | 0.61 | Why? |
| Metapneumovirus | 1 | 2017 | 465 | 0.54 | Why? |
| Paramyxoviridae Infections | 1 | 2017 | 364 | 0.53 | Why? |
| Enterovirus D, Human | 2 | 2019 | 96 | 0.35 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2017 | 1234 | 0.34 | Why? |
| Seasons | 2 | 2017 | 4071 | 0.34 | Why? |
| Environmental Exposure | 3 | 2020 | 1558 | 0.27 | Why? |
| Enterovirus Infections | 2 | 2019 | 404 | 0.26 | Why? |
| Contact Tracing | 6 | 2020 | 8448 | 0.22 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.22 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.21 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 5 | 2020 | 8843 | 0.20 | Why? |
| North Dakota | 1 | 2017 | 21 | 0.18 | Why? |
| Missouri | 1 | 2018 | 274 | 0.17 | Why? |
| Infant | 8 | 2021 | 30274 | 0.15 | Why? |
| Population Surveillance | 4 | 2019 | 4967 | 0.13 | Why? |
| Camelus | 2 | 2020 | 1425 | 0.13 | Why? |
| Glycated Hemoglobin A | 1 | 2021 | 1316 | 0.12 | Why? |
| Rhinovirus | 1 | 2018 | 979 | 0.12 | Why? |
| Symptom Assessment | 3 | 2021 | 4967 | 0.12 | Why? |
| Syphilis | 1 | 2016 | 318 | 0.11 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.11 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.11 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2017 | 846 | 0.10 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.10 | Why? |
| Public Health Surveillance | 2 | 2020 | 3129 | 0.10 | Why? |
| Patient Care Management | 1 | 2021 | 1514 | 0.10 | Why? |
| Respiratory Tract Infections | 2 | 2021 | 6817 | 0.10 | Why? |
| Colorado | 2 | 2021 | 434 | 0.10 | Why? |
| Illinois | 2 | 2020 | 468 | 0.09 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.09 | Why? |
| Infant, Newborn | 3 | 2020 | 23105 | 0.09 | Why? |
| Child | 9 | 2021 | 70012 | 0.09 | Why? |
| Diabetes Mellitus | 2 | 2021 | 8207 | 0.09 | Why? |
| United States | 9 | 2021 | 46150 | 0.09 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.09 | Why? |
| Outpatients | 1 | 2021 | 3417 | 0.09 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.08 | Why? |
| Georgia | 2 | 2021 | 955 | 0.08 | Why? |
| Saudi Arabia | 4 | 2020 | 4423 | 0.08 | Why? |
| Homosexuality, Male | 1 | 2016 | 1158 | 0.08 | Why? |
| Coronavirus Infections | 12 | 2020 | 253789 | 0.08 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.08 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.07 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.07 | Why? |
| Phylogeny | 3 | 2018 | 13341 | 0.07 | Why? |
| Male | 16 | 2021 | 367725 | 0.07 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.07 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.07 | Why? |
| Female | 16 | 2021 | 380317 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.06 | Why? |
| Aged | 11 | 2021 | 215776 | 0.06 | Why? |
| Travel-Related Illness | 2 | 2020 | 1357 | 0.06 | Why? |
| Health Promotion | 1 | 2016 | 2020 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.06 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Humans | 24 | 2021 | 930598 | 0.05 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.05 | Why? |
| Retrognathia | 1 | 2020 | 17 | 0.05 | Why? |
| Family Characteristics | 2 | 2021 | 2551 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Adult | 12 | 2021 | 244371 | 0.05 | Why? |
| DNA Viruses | 1 | 2021 | 184 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2019 | 11041 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.04 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Dyspnea | 2 | 2021 | 3847 | 0.04 | Why? |
| Cough | 2 | 2021 | 4891 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Multimorbidity | 1 | 2021 | 703 | 0.04 | Why? |
| Myalgia | 1 | 2021 | 1015 | 0.04 | Why? |
| Sequence Homology | 1 | 2016 | 448 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.04 | Why? |
| Washington | 1 | 2020 | 1722 | 0.04 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.03 | Why? |
| Social Media | 1 | 2016 | 5798 | 0.03 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Fever | 2 | 2021 | 7795 | 0.03 | Why? |
| Genes, Viral | 1 | 2019 | 1428 | 0.03 | Why? |
| Wales | 1 | 2016 | 758 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Travel | 2 | 2020 | 7220 | 0.03 | Why? |
| Sexual Partners | 1 | 2016 | 612 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2016 | 1638 | 0.03 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.02 | Why? |
| History, 21st Century | 1 | 2016 | 1849 | 0.02 | Why? |
| Cities | 1 | 2020 | 4937 | 0.02 | Why? |
| Cluster Analysis | 1 | 2016 | 3001 | 0.02 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2016 | 2830 | 0.02 | Why? |
| Sexual Behavior | 1 | 2016 | 1322 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2016 | 3239 | 0.02 | Why? |
| Rural Population | 1 | 2016 | 2408 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| China | 2 | 2020 | 50654 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2016 | 2782 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.02 | Why? |
| Patient Acceptance of Health Care | 1 | 2021 | 5002 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Animals | 2 | 2020 | 78931 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Viral Load | 1 | 2019 | 15850 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Genome, Viral | 1 | 2016 | 13157 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| RNA, Viral | 1 | 2019 | 32276 | 0.01 | Why? |
Midgley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(254)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_